InvestorsHub Logo
Followers 90
Posts 17402
Boards Moderated 0
Alias Born 09/06/2006

Re: ilovetech post# 679272

Sunday, 03/17/2024 5:26:58 PM

Sunday, March 17, 2024 5:26:58 PM

Post# of 700310

In any case, Yervoy and Opdivo won approvals for adding two months to mOS. The bar set so low, you could walk over it.


Have no idea what approval you are talking about. The approval for Y+O in thoratic was 18.1 vs 14.1mOS against an actual randomized comp. As opposed to DC-L claimed 2.8 month mOS benefit against other trials.

You also rant about how chemo is evil and should be banned. Care to explain to Garry why you think he should have died instead of being cured?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News